James, N. D., Wiel, J. V. D., Santis, M. D., Din, O. S., Ford, D., Hafeez, S., Huddart, R. A., Hughes, A., Iddenden, J., Mir, R., Bonner, C. V. -., Zarkar, A., Pirrie, S., Hussain, S. A. (2026). Feasibility and safety results from RAD-IO: A multi-stage trial of durvalumab with chemoradiotherapy with 5-fluorouracil and mitomycin C in patients with muscle-invasive bladder cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4504